From Image to Eligibility.Under 1 Hour.

Precision for the next generation of ophthalmic trials.

Key Statistics

Built for speed. Proven at scale.

Operational performance, quality assurance, and scientific scale across OIRRC-supported ophthalmic trials.

Speed
45 min Average eligibility TAT Average time from image receipt to eligibility decision, aligned with the "under 1 hour" homepage promise.
Quality
99.2% QC consistency Consistent, human-verified quality control across imaging review workflows.
Experience
60+ Trials supported Total ophthalmic clinical trials supported across OIRRC-backed programs.
Footprint
≈800 Sites supported Nearly 800 study sites supported across OIRRC trial operations.

Additional operating and scientific scale

Expanded metrics retained from the approved reference snapshot.

5 Continents, 24/7 reading Global ophthalmic coverage with around-the-clock operational continuity.
30+ Expert graders Specialized clinical image graders supporting endpoint review quality.
40K+ Images ingested Proven throughput across large imaging datasets and trial workflows.
41 Peer-reviewed publications Scientific contributions demonstrating the depth of OIRRC's research heritage.
1000+ Investigators worked with A broad investigator network across OIRRC-supported ophthalmic studies.
<1 wk Contract to first reads Fast study startup from agreement to first image-read operations.

Our Services

End-to-end clinical trial support — from protocol design through imaging analysis — delivered at the speed your science needs.

Service
Protocol Development

Protocol Development

Service
Site Selection & Management

Site Selection & Management

Service
Device Certification

Device Certification

Service
Photographer Certification

Photographer Certification

Service
Lane & BCVA Certification

Lane & BCVA Certification

Service
Eligibility Assessment

Eligibility Assessment

View All Services →

One platform. Every stage of your ophthalmic trial.

Automated capture. Audit-ready reads. Sponsor-visible trial progress — always.

Explore our Technology →
AI-Powered. Human-Verified. Trial-Ready.
OIRRC has established and operates under robust data security and compliance frameworks aligned with ISO 27001, HIPAA, GDPR, and 21 CFR Part 11 requirements

Trusted by industry leaders

"

“I am pleased to commend OIRRC for being an exceptional partner throughout our clinical development process. Their team has consistently gone above and beyond, from expediting certification requests for sites working within tight SIV windows to handling eligibility reviews in a very short time. A successful clinical trial has a lot of moving parts working together in unison. OIRRC demonstrated their commitment to being a dedicated partner. One thing that stood out was their accessibility – whether it’s an imaging question or occasionally confirming a PI’s findings, they are always available via texts and calls. In addition, the willingness to accommodate an ad-hoc audit-type visit at short notice at their offices further showcased their transparency and commitment to our collaboration. Even after the study completion, OIRRC have continued to assist us by gathering supporting images that were instrumental in confirming positive outcomes for our data presentations. Their dedication to delivering quality results in time makes them an invaluable partner in ophthalmic clinical trials.”

Raj Agrawal, MD MS
VP Clinical Development, Rezolute Inc.
"

“Boehringer Ingelheim and OIRRC have fostered an exceptional partnership, collaborating closely with an engaged trial team to execute a PhI/IIa study in patients with wet AMD. Throughout our collaboration, OIRRC demonstrated unwavering dedication to Boehringer’s retinal health program, delivering outstanding service across all fronts. Key accomplishments include: • Developing user-friendly imaging manuals for various devices and swiftly certifying multiple sites across several countries. • Confirming eligibility within a 48-hour timeframe based on OCT and CFP data. • Offering valuable scientific and medical insights on images as required during the trial. • Providing real-time access to all study data. • Adapting promptly to evolving trial needs. • Delivering several interim reports and a comprehensive final analysis encompassing various custom parameters derived from SD-OCT, OCTA, multi-field CFP, ultra-widefield CFP, and FA data. Our collaboration with OIRRC was characterized by true partnership, agility, and effectiveness, particularly as the trial underwent multiple re-designs. We deeply appreciate OIRRC’s meticulous attention to detail and proactive approach in addressing issues related to patient safety and data integrity. I wholeheartedly recommend their services.”

Daniel Peter
Clinical Trial Lead, Boehringer Ingelheim
"

"OIRRC has proven to be not just a reliable Reading Center that provides timely review of study images and delivery of data transfer, but they are also a valuable partner in collaborating with our scientific team to find innovative solutions to grading challenges."

Mei Tran
Clinical Project Manager, Belite Bio
"

“As an expert in the field of ophthalmic & vitreoretinal clinical trials, with over 300 peer-reviewed publications and more than 200 international keynote presentations, I, David Almeida, MD, MBA, PhD, have had the pleasure of collaborating with the Ocular Imaging Research and Reading Center (OIRRC). My experience with OIRRC has been nothing short of exceptional, thanks to their cutting-edge technology and highly professional team! Working with OIRRC, I was particularly impressed by their advanced imaging methodologies and robust data analysis capabilities, which have significantly enhanced the quality of our clinical trials. Their dedication to providing timely and accurate results has led to improved outcomes in our research projects, ultimately benefiting patient care. The team at OIRRC exhibits unparalleled expertise and commitment, making them a vital partner in our endeavors. Their ability to deliver high-quality, reliable results – under tight timelines – has been instrumental in advancing our research objectives by streamlined imaging operations. I wholeheartedly recommend OIRRC to any organization looking to leverage top-notch ocular imaging and research services. Their contribution is invaluable in the pursuit of excellence in ocular health research and patient care.”

David Almeida, MD
Principle Investigator

Ready to accelerate your ophthalmic trial?